Advertisement
Screener

Omada Health, Inc. (OMDA) Overview

Omada Health, Inc. (OMDA) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.08; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.05; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.06; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.24; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$10.39$12.51$15.05$18.12$21.80$26.242025-11-062026-11-06$10.39$12.68$15.48$18.88$23.04$28.122025-06-062026-11-06$10.39$12.68$15.48$18.88$23.04$28.122025-06-062026-11-06$10.39$12.68$15.48$18.88$23.04$28.122025-06-062026-11-06$10.39$12.68$15.48$18.88$23.04$28.122025-06-062026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$15.10
Previous close
$19.37
Change
-$4.27
Change (%)
-22.04%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

OMDA
+22.75%
S&P 500
(m)

1 year

OMDA
-13.22%
S&P 500
(m)

3 years

OMDA
(m)
S&P 500
(m)

5 years

OMDA
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.08

-1.23-0.86-0.48-0.110.2631 Mar 2025: estimate (m); actual -1.1531 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2430 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0630 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0531 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.0830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.08(m)(m)
1 Jan 202631 Mar 2026(m)-0.05(m)(m)
1 Jul 202530 Sept 2025(m)-0.06(m)(m)
1 Apr 202530 Jun 2025(m)-0.24(m)(m)
1 Jan 202531 Mar 2025(m)-1.15(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.35

-9.60-7.24-4.88-2.53-0.1731 Dec 2023: estimate (m); actual -9.5231 Dec 2023(m)31 Dec 2024: estimate (m); actual -6.1131 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.3531 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.35(m)(m)
1 Jan 202431 Dec 2024(m)-6.11(m)(m)
1 Jan 202331 Dec 2023(m)-9.52(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 87.83M ■ Earnings 5.29M — Profit margin 6.03%

-14.10M-5.7%23.52M-1.2%61.14M3.3%98.76M7.8%30 Sept 2025: revenue 68.03M; earnings -3.18M; profit margin -4.67%30 Sept 202531 Dec 2025: revenue 75.85M*; earnings 5.16M*; profit margin 6.80%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 78.05M; earnings -2.97M; profit margin -3.81%31 Mar 202630 Jun 2026: revenue 87.83M; earnings 5.29M; profit margin 6.03%30 Jun 2026

31 Dec 2025 ■ Revenue 260.21M ■ Earnings -12.78M — Profit margin -4.91%

-106.84M-56.0%28.62M-38.6%164.08M-21.3%299.54M-3.9%31 Dec 2023: revenue 122.78M; earnings -67.51M; profit margin -54.98%31 Dec 202331 Dec 2024: revenue 169.80M; earnings -47.14M; profit margin -27.76%31 Dec 202431 Dec 2025: revenue 260.21M; earnings -12.78M; profit margin -4.91%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$15.10(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$15.10High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning OMDA

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$4.30M
Profit margin
1.39%
Return on assets · 12 month
1.36%
Index membership
(m)
Employees
916.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.48M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-9.36%*
Total return · month
-18.24%*
Total return · quarter
-10.61%*
Total return · half year
63.32%*
Total return · year to date
22.75%*
Total return · 1 year
-13.22%*
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$309.76M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Omada Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1611115
Industry (SIC)
8000 Services-Health Services
Country of operation
United States
Business address
611 GATEWAY BLVD., SUITE 120, SOUTH SAN FRANCISCO, California, 94080, United States
Fiscal year end
1231
Phone
888-987-8337

Similar stocks

Stock NameCountryMarket CapPE Ratio
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86